The Supreme Industries Limited (SUPREMEIND.NS)
INR 3447.7
(-2.58%)
INR 3447.7
(-2.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 101.34 Billion | 92.01 Billion | 77.31 Billion | 62.99 Billion | 54.66 Billion | 55.63 Billion |
| Cost of Revenue | 79.27 Billion | 68.65 Billion | 53.99 Billion | 40.8 Billion | 36.15 Billion | 38.57 Billion |
| Gross Profit | 22.06 Billion | 23.35 Billion | 23.32 Billion | 22.18 Billion | 18.5 Billion | 17.06 Billion |
| Operating Expenses | 31.6 Billion | 13.99 Billion | 13.05 Billion | 11.44 Billion | 11.88 Billion | 11.06 Billion |
| Selling, General and Administrative Expenses | 9.57 Billion | 2.92 Billion | 2.39 Billion | 2.11 Billion | 2.23 Billion | 2.27 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 11.06 Billion | 10.66 Billion | 9.33 Billion | 9.64 Billion | 1.8 Million |
| Cost and Expenses | 88.85 Billion | 82.65 Billion | 67.04 Billion | 52.25 Billion | 48.03 Billion | 49.64 Billion |
| Operating Income | 12.48 Billion | 11.19 Billion | 12.17 Billion | 12.2 Billion | 6.76 Billion | 5.99 Billion |
| Interest Expense | 121.9 Million | 80.2 Million | 41.5 Million | 209 Million | 282.4 Million | 312.2 Million |
| Income Tax Expense | 3.35 Billion | 2.45 Billion | 2.63 Billion | 2.34 Billion | 1.73 Billion | 2.15 Billion |
| Earnings before Tax | 12.98 Billion | 11.11 Billion | 12.31 Billion | 12.12 Billion | 6.41 Billion | 6.76 Billion |
| Net Income | 10.69 Billion | 8.65 Billion | 9.68 Billion | 9.78 Billion | 4.67 Billion | 4.61 Billion |
| Earnings Per Share Basic | 84.21 | 68.12 | 76.24 | 77.00 | 36.80 | 36.29 |
| Earnings Per Share Diluted | 84.21 | 68.12 | 76.24 | 77.00 | 36.80 | 36.29 |
| Weighted Average Shares Outstanding | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million | 127.02 Million |
| Gross Margin | 0.22 | 0.25 | 0.30 | 0.35 | 0.34 | 0.31 |
| EBIT Margin | 0.16 | 0.15 | 0.19 | 0.23 | 0.16 | 0.14 |
| Profit Margin | 0.11 | 0.09 | 0.13 | 0.16 | 0.09 | 0.08 |
| EBITDA | 16.09 Billion | 12.28 Billion | 12.61 Billion | 12.98 Billion | 8.45 Billion | 8.81 Billion |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.16 | 0.19 | 0.12 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.72 Billion | 26.36 Billion | 30.07 Billion | 101.34 Billion | 24.49 Billion | 23.08 Billion |
| Cost of Revenue | 14.88 Billion | 20.89 Billion | 23.12 Billion | 79.27 Billion | 16.4 Billion | 15.35 Billion |
| Gross Profit | 7.84 Billion | 5.46 Billion | 6.94 Billion | 22.06 Billion | 8.08 Billion | 7.73 Billion |
| Operating Expenses | 5.55 Billion | 2.45 Billion | 2.81 Billion | 9.57 Billion | 5.07 Billion | 4.88 Billion |
| Selling, General and Administrative Expenses | 2.63 Billion | 2.45 Billion | 2.81 Billion | - | 2.34 Billion | 2.32 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5.55 Billion | 214.4 Million | 180.9 Million | 656.9 Million | 207.1 Million | 126.9 Million |
| Cost and Expenses | 20.43 Billion | 23.35 Billion | 25.94 Billion | 88.85 Billion | 21.47 Billion | 20.24 Billion |
| Operating Income | 2.29 Billion | 3.01 Billion | 4.13 Billion | 12.48 Billion | 3.43 Billion | 3.21 Billion |
| Interest Expense | 26.2 Million | 33.3 Million | 77.2 Million | 161.2 Million | 51.6 Million | 15.5 Million |
| Income Tax Expense | 629.3 Million | 835.7 Million | 1.09 Billion | 3.35 Billion | 818 Million | 762.9 Million |
| Earnings before Tax | 2.69 Billion | 3.19 Billion | 4.23 Billion | 12.98 Billion | 3.37 Billion | 3.19 Billion |
| Net Income | 2.06 Billion | 2.73 Billion | 3.54 Billion | 10.69 Billion | 2.56 Billion | 2.43 Billion |
| Earnings Per Share Basic | 16.26 | 21.52 | 27.93 | - | 20.17 | 19.14 |
| Earnings Per Share Diluted | 16.26 | 21.52 | 27.93 | - | 20.17 | 19.14 |
| Weighted Average Shares Outstanding | 127.06 Million | 127.02 Million | 127.03 Million | 127.03 Million | 127.02 Million | 127.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.06 Million | 127.02 Million | 127.03 Million | 127.03 Million | 127.02 Million | 127.02 Million |
| Gross Margin | 0.35 | 0.21 | 0.23 | 0.22 | 0.33 | 0.33 |
| EBIT Margin | 0.16 | 0.15 | 0.16 | - | 0.17 | 0.17 |
| Profit Margin | 0.09 | 0.10 | 0.12 | 0.11 | 0.10 | 0.11 |
| EBITDA | 3.62 Billion | 3.87 Billion | 4.9 Billion | - | 4.2 Billion | 3.92 Billion |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.14 | 0.12 | 0.14 | 0.14 |
VPLM
JUBLPHARMA
300220
INSE
LIO
OXBR